Navigation Links
Transforming the physician workforce through competitive graduate education funding
Date:11/11/2013

unding mechanism is the "inflexible GME pipeline" that is anchored to the number of residents funded at the time of the passage of the Balanced Budget Act of 1997. Some expansion has occurred but mainly in subspecialties, ignoring the need for additional primary care physicians.

To improve the physician workforce, the authors recommend a new system of funding that is responsive to workforce needs, rewards innovation, and uses explicit outcome objectives to evaluate training programs. The funding would be publicly guided and awarded through competitive funding, similar to the process of awarding National Institute of Health peer-reviewed research grants.

"For the physician workforce to change and improve, there must be a trusted public entity that regularly sets overall goals for training direction and pipeline size," the authors said. The entity should be a federal advisory committee composed of the public, public health experts, health care systems, payers and medical educators.

These goals would guide the development of annual requests for funding proposals. Residency programs would be required to apply and compete for GME funding once every 10 years. This means that each year 10 percent of the nation's training programs would be reviewed. New programs would compete for funding. Existing programs that score poorly would receive reduced funding, while meritorious programs could grow. Awards would be for 10 years to enable teaching organization stability.

Applications would be reviewed through study sections. Programs would also need to report performance measures that include educational capacity, processes and outcomes. These measures would be available to the public including fourth year medical students who are choosing residency programs.

Funding would no longer be linked to residents' time caring for Medicare beneficiaries in acute care settings. "Indirect GME funding would no longer reward the very inefficiencie
'/>"/>

Contact: Annmarie Christensen
annmarie.christensen@dartmouth.edu
603-653-0897
Dartmouth-Hitchcock Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Trivedi Masters Invite People across the Globe for the Historic Event, 'TRANSFORMING HUMANITY'
2. New Logo Better Communicates Niche of Scott Sheldon, LLC: Transforming Supply Chains
3. Colorado Takes a Huge Step toward Transforming the Family Dining Experience
4. Scott Sheldon Unveils New Web Design: Transforming Supply Chains
5. Transforming America by redirecting wasted health care dollars
6. Innovaacom Announces November Launch of New Hospital-Based Physician Training Program
7. Online course improves physicians skill level for detecting skin cancer
8. Health Care Without Harm and Physicians for Social Responsibility Report: One-Quarter of CA Hospitals Are Committed to Sustainable Food as Center of Healing Mission
9. Endocrinologist Dr. Reema Patel Joins Raritan Bay Physicians’ Group, PC
10. Physician shortage could be cut by new primary care models, study finds
11. Electronic and Internet health tools may decrease in-person physician visits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/20/2014)... Xarelto bleeding lawsuits filed by men and ... other serious side effects will be consolidated in the ... pretrial proceedings, Wright & Schulte LLC reports. The U.S. ... Friday to transfer 21 Xarelto lawsuits and over 30 ... the Louisiana district court for coordination by Judge Eldon ...
(Date:12/19/2014)... 20, 2014 Today, Balfleet.com , ... outfits, announces its formal dress promotion. All the old ... to 60% off. , Balfleet.com is well-known for its ... dresses, prom dresses, cocktail dresses and more. Its formal ... money-back guarantee, and they can create an elegant look ...
(Date:12/19/2014)... 19, 2014 Energy Textiles is ... now available. Celliant, the world’s leading responsive textile, ... pillowcases. , There are a number of benefits ... increased oxygenation and balanced body temperature; which can ... pain relief; enhanced athletic performance; and overall wellness. ...
(Date:12/19/2014)... 19, 2014 Eufaula, Oklahoma, located just ... Eufaula, the state’s largest lake with more than 600 ... home to a little more than 3,000 residents, hosted ... Saturday, the 6th of December. , Featuring Santa, Christmas ... downtown Eufaula on Main Street. Narconon Arrowhead’s parade ...
(Date:12/19/2014)... December 20, 2014 The print component ... and Business subscription of the Toronto Star, with a ... of 622,169. The digital component is distributed nationally through ... of top news sites and partner outlets. To explore ... . , The publication features an exclusive interview ...
Breaking Medicine News(10 mins):Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 2Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 3Health News:Xarelto Bleeding Lawsuits Consolidated To Louisiana Federal Court For Multi-District Litigation Reports Wright & Schulte LLC 4Health News:Balfleet.com Announces Its Formal Dress Promotion For 2015 2Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 3Health News:Mark DeMontis, Founder of Courage Canada, shares his passion for bringing hockey to those affected by blindness in Mediaplanet’s “Vision and Hearing” campaign 2
... Service Corporation,s Technology Investments Streamline ... HealthLeaders-InterStudy, NASHVILLE, Tenn., Aug. 5 ... intelligence, reports that Health,Care Service Corporation is ... serve its members. According to the,new report ...
... (Nasdaq: NKTR ) today announced the company,s financial ... 2008., Cash, cash equivalents, and short-term investments were ... at March 31, 2008., Revenue for the three ... to revenue of $65.9 million in the second quarter ...
... 6 Nektar,Therapeutics (Nasdaq: NKTR ) today ... the position of Senior Vice President of Drug,Development ... Dr.,Moreadith will report to Nektar,s President and Chief ... lead Clinical Drug Development, Clinical,Pharmacology and Toxicology, and ...
... 9.3 percent (constant currency) - Execution of strategic ... guidance based on year-to-date ... performance and operational momentum, BATESVILLE, Ind., Aug. 6 ... results for its fiscal,third quarter ended June 30, 2008 -- ...
... Pa., Aug. 6 West Pharmaceutical,Services, Inc. (NYSE: ... Vice,President and Chief Financial Officer, and Michael Anderson, ... will be presenting at,the CJS Securities 8th Annual ... NY, on August 12, 2008. A copy of ...
... A drug-like molecule called Wnt can be substituted for ... to adult cells to reprogram them to an embryonic-stem-cell-like ... embryonic stem-cell-like cells, known as induced pluripotent (IPS) cells, ... diabetes. , Demonstrated in mice, the elimination of ...
Cached Medicine News:Health News:Insurance Giant Leverages Technology to Enhance Offerings 2Health News:Nektar Therapeutics Announces Second Quarter 2008 Results 2Health News:Nektar Therapeutics Announces Second Quarter 2008 Results 3Health News:Nektar Therapeutics Announces Second Quarter 2008 Results 4Health News:Nektar Therapeutics Announces Second Quarter 2008 Results 5Health News:Nektar Therapeutics Announces Second Quarter 2008 Results 6Health News:Nektar Therapeutics Announces Second Quarter 2008 Results 7Health News:Nektar Therapeutics Announces Second Quarter 2008 Results 8Health News:Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer 2Health News:Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer 3Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 2Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 3Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 4Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 5Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 6Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 7Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 8Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 9Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 10Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 11Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 12Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 13Health News:Hill-Rom Reports Third Quarter Revenue Growth of 11.7 Percent to $366.8 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.34, an Increase of 89 Percent From the Prior Year 14Health News:Recipe for cell reprogramming adds protein 2
(Date:12/19/2014)... and LYON, France , Dec. ... LLY ) and Adocia (Euronext Paris: FR0011184241 – ... developing an ultra-rapid insulin, known as BioChaperone Lispro, for ... diabetes. BioChaperone Lispro relies on Adocia,s proprietary BioChaperone® technology ... Lilly and Adocia will develop BioChaperone Lispro with the ...
(Date:12/17/2014)... , December 17, 2014 Revenue and ... expenditure on research and development In the past ... revenue by two percent to EUR 4.287 billion (last year: ... by 14 percent to EUR 360 million. "Overall, 2013/14 was ... Michael Kaschke , President and CEO of Carl Zeiss ...
(Date:12/17/2014)... Ariz. , Dec. 17, 2014  Beamz ... state-of-the-art interactive music products, today announced that it ... a leading manufacturer and supplier of innovative prosthetic, ... As part of the agreement, RSL Steeper ... bundled solution specifically configured for use within UK ...
Breaking Medicine Technology:Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3ZEISS Asserts its Position in Difficult Environment 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3
... NEWTOWN, Pa., Dec. 1, 2011 HeartSine ® Technologies, ... announced today that it is the exclusive provider of ... nation,s second largest nursing facility company. As part ... Access Defibrillator , HeartSine,s lifesaving product for the treatment ...
... (Nasdaq: MYL ) today announced that its ... received tentative approval from the U.S. Food and Drug ... Relief (PEPFAR) for its New Drug Application (NDA) for ... This product is the first heat-stable, fixed-dose ...
Cached Medicine Technology:HeartSine® Technologies Now Exclusive Provider of Lifesaving AEDs to Golden LivingCenters 2HeartSine® Technologies Now Exclusive Provider of Lifesaving AEDs to Golden LivingCenters 3Mylan Receives Tentative FDA Approval Through PEPFAR for First Heat-Stable, Fixed-Dose Combination of Atazanavir Sulfate and Ritonavir Tablets for HIV/AIDS 2
The Clearview hCG Test is for the rapid detection of human chorionic gonadotropin (hCG) in urine specimens. This test kit is used to obtain a visual, qualitative result and is intended for professio...
... the finest surgical-quality loupes available ... standard for innovative optical design, combining ... Delivering optimum performance with maximum comfort, ... for medical professionals worldwide. All SheerVision ...
... Experience the finest surgical-quality loupes available ... the standard for innovative optical design, ... Delivering optimum performance with maximum comfort, ... for medical professionals worldwide. Make both ...
... SheerVision have addressed a key need of ... with light-weight comfort for everyday use. ... as 1.5 ounces when included with a ... either a flip-up or through-the-lens (TTL) design. ...
Medicine Products: